Kerstin Bartelheim
Augsburg, BY 86156, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Improved 6-year overall survival in AT/RT - results of the registry study Rhabdoid 2007.
Journal: Cancer medicine
Published: January 04, 2016
Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor.
Journal: Pediatric blood & cancer
Published: October 20, 2014
Synchronous congenital malignant rhabdoid tumor of the orbit and atypical teratoid/rhabdoid tumor--feasibility and efficacy of multimodal therapy in a long-term survivor.
Journal: Cancer genetics
Published: February 28, 2014
Identification of genes involved in the biology of atypical teratoid/rhabdoid tumours using Drosophila melanogaster.
Journal: Nature communications
Published: November 20, 2013
Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.
Journal: International journal of cancer
Published: October 22, 2013
Favorable outcome of patients affected by rhabdoid tumors due to rhabdoid tumor predisposition syndrome (RTPS).
Journal: Pediatric blood & cancer
Published: August 07, 2013
High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB).
Journal: Bone marrow transplantation
Published: July 09, 2013
High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors.
Journal: Genes, chromosomes & cancer
Published: July 01, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026